ZB
TAK icon

Zions Bancorporation’s Takeda Pharmaceutical TAK Stock Holding History

Zions Bancorporation’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$4.91K Hold
371
– – ﹤0.01% 707
2024
Q3 		$5.28K Buy
371
+152
+69% +$2.16K ﹤0.01% 705
2024
Q2 		$2.83K Sell
219
-250
-53% -$3.31K ﹤0.01% 816
2024
Q1 		$6.51K Hold
469
– – ﹤0.01% 721
2023
Q4 		$6.69K Hold
469
– – ﹤0.01% 712
2023
Q3 		$7.25K Sell
469
-83
-15% -$1.28K ﹤0.01% 683
2023
Q2 		$8.67K Sell
552
-144
-21% -$2.36K ﹤0.01% 660
2023
Q1 		$11.5K Buy
696
+8
+1% +$127 ﹤0.01% 620
2022
Q4 		$10.7K Buy
688
+469
+214% +$6.55K ﹤0.01% 693
2022
Q3 		$3K Sell
219
-47
-18% -$654 ﹤0.01% 845
2022
Q2 		$4K Sell
266
-374
-58% -$5.34K ﹤0.01% 904
2022
Q1 		$9K Buy
640
+383
+149% +$5.62K ﹤0.01% 847
2021
Q4 		$4K Sell
257
-307
-54% -$4.31K ﹤0.01% 876
2021
Q3 		$9K Sell
564
-287
-34% -$4.82K ﹤0.01% 752
2021
Q2 		$14K Sell
851
-445
-34% -$7.58K ﹤0.01% 664
2021
Q1 		$24K Sell
1,296
-43
-3% -$774 ﹤0.01% 545
2020
Q4 		$24K Sell
1,339
-964
-42% -$16.9K ﹤0.01% 526
2020
Q3 		$41K Buy
2,303
+1,909
+485% +$34.8K 0.01% 411
2020
Q2 		$7K Sell
394
-806
-67% -$14.5K ﹤0.01% 704
2020
Q1 		$18K Buy
1,200
+185
+18% +$3.35K ﹤0.01% 484
2019
Q4 		$20K Buy
1,015
+47
+5% +$899 ﹤0.01% 606
2019
Q3 		$17K Buy
968
+185
+24% +$3.2K ﹤0.01% 619
2019
Q2 		$14K Sell
783
-2,001
-72% -$36.4K ﹤0.01% 598
2019
Q1 		$57K Buy
+2,784
New +$56K 0.01% 388

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Zions Bancorporation's TAK Position: Q4 2024 in Review

Zions Bancorporation held its Takeda Pharmaceutical (TAK) position steady in Q4 2024 at 371 shares worth $4.91K. The position accounts for ﹤0.01% of the portfolio, ranked #707.

Zions Bancorporation first reported a position in TAK in Q1 2019 and has held it in 24 quarters since. The position peaked at $57K in Q1 2019. 300 funds tracked by Wall St. Rank hold TAK as of Q4 2024.

  • Zions Bancorporation held 371 shares of Takeda Pharmaceutical worth $4.91K as of Q4 2024.
  • Zions Bancorporation left its Takeda Pharmaceutical share count unchanged in Q4 2024.
  • Takeda Pharmaceutical made up ﹤0.01% of Zions Bancorporation's portfolio in Q4 2024, its #707 holding.
  • Zions Bancorporation first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 24 quarters since.
  • Zions Bancorporation's Takeda Pharmaceutical position peaked at $57K in Q1 2019.
  • 300 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2024.

Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.